The clearance of Keytruda QLEX follows similar approvals for Bristol Myers and Roche. Elsewhere, MBX’s parathyroidism drug ...
The collapse in value of many biotechs over the past few years has created an opportunity for specialists like Xoma to “do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback